DEXCOM

CEO: Kevin Sayer

GAAP Net loss: $127.1 million in 2018; $50.2 million in 2017

Headquarters: San Diego

Founded: 1999

Stock symbol and exchange: DXCM on Nasdaq

Company description: Dexcom’s flagship product is its G6 diabetes monitoring system, which doesn’t require finger prick blood draws for calibration.

Dexcom will lay off 350 workers largely in San Diego and Arizona as part of a restructuring, a move disclosed along with fourth quarter earnings that showed strong topline growth...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129